A practical reference on GHRH analogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-04-04 and is reviewed periodically as new material appears.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Studies of the compound rely on imaging and laboratory endpoints rather than on symptoms alone. Visceral adipose tissue is usually quantified by computed tomography or magnetic resonance imaging at the level of the abdomen, with waist circumference serving as a cheaper but less specific proxy. Blood work tracks insulin-like growth factor 1, fasting glucose, glycated hemoglobin, and lipid fractions. In the pivotal trials the imaging endpoint fell by roughly fifteen to twenty percent over six months, subcutaneous fat changed little, and the visceral fat returned toward baseline after treatment stopped, a pattern that shapes how clinicians discuss durability.
Whether the drug improves hard clinical outcomes is not settled. No completed trial has shown a reduction in heart attacks or strokes among treated patients, although a dedicated cardiovascular outcomes study has been discussed in the literature. Investigators have also examined hepatic fat in people with HIV and fatty liver disease, cognitive measures in small cohorts, and changes in bone density. Regulatory labeling emphasizes monitoring of insulin-like growth factor 1 because supraphysiologic levels raise questions about tissue growth, and the clinical significance of that signal remains an open question rather than a demonstrated harm.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
interphase All stages of the cell cycle excluding cell division. A typical cell spends most of its life in interphase, during which it conducts everyday metabolic activities as well as the complete replication of its genome in preparation for mitosis or meiosis.
At the same time, Kissinger met with Dobrynin to warn him that Nixon was a dangerous man who wanted to escalate the Vietnam war. In April 1969, North Korea shot down a U.S. Navy plane on a spy mission, killing 31 airmen. Kissinger wanted to bomb a North Korean air base in retaliation, being opposed by the Defense Secretary Melvin Laird, the Secretary of State William Rogers and General Earle Wheeler, the chairman of the joint chiefs of staff, who all warned that to bomb North Korea might start a second war in Asia. Kissinger argued that bombing North Korea would help end the Vietnam war, saying: "Hanoi might say, 'This guy [Nixon] is becoming irrational'-and we'd better settle with him". Unable to gain support at the National Security Council, Kissinger appealed to Nixon's Domestic Affairs Adviser, John Ehrlichman, saying that, though striking in North Korea might cause a second Korean war, it might also help with the Vietnam war. When Ehrlichman asked Kissinger how far things might escalate if the U.S. bombed North Korea, he was told: "Well, it could go nuclear". Ehrlichman came away convinced that Kissinger with his thick German accent, academic titles, advocacy of a ruthless foreign policy and a role as a senior presidential adviser seemed too much like the eponymous character of the 1964 black comedy Dr. Strangelove and advised Nixon not to strike North Korea, advice that was accepted. Starting in April 1969, Kissinger pressed for a plan code-named Operation Duck Hook, which would see the United States return to bombing North Vietnam and possibly use nuclear weapons.
Hydrogen peroxide has been classified by the American Conference of Governmental Industrial Hygienists (ACGIH) as a "known animal carcinogen, with unknown relevance on humans". For workplaces where there is a risk of exposure to the hazardous concentrations of the vapours, continuous monitors for hydrogen peroxide should be used. Information on the hazards of hydrogen peroxide is available from OSHA and from the ATSDR.
The oil diffusion pump is operated with an oil of low vapor pressure. The high speed jet is generated by boiling the fluid and directing the vapor through a jet assembly. Note that the oil is gaseous when entering the nozzles. Within the nozzles, the flow changes from laminar to supersonic and molecular. Often, several jets are used in series to enhance the pumping action. The outside of the diffusion pump is cooled using either air flow, water lines or a water-filled jacket. As the vapor jet hits the outer cooled shell of the diffusion pump, the working fluid condenses and is recovered and directed back to the boiler. The pumped gases continue flowing to the base of the pump at increased pressure, flowing out through the diffusion pump outlet, where they are compressed to ambient pressure by the secondary mechanical forepump and exhausted. Unlike turbomolecular pumps and cryopumps, diffusion pumps have no moving parts and as a result are quite durable and reliable. They can function over pressure ranges of 1×10−10 to 1×10−2 mbar (1×10−8 to 1 Pa). They are driven only by convection and thus have a very low energy efficiency. One major disadvantage of diffusion pumps is the tendency to backstream oil into the vacuum chamber. This oil can contaminate surfaces inside the chamber or upon contact with hot filaments or electrical discharges may result in carbonaceous or siliceous deposits.
Sources: en.wikipedia.org
In chromatography, endcapping refers to the replacement of accessible silanol groups in a bonded stationary phase by trimethylsilyl groups. End-capped columns have much lower residual silanol group activity compared to non-endcapped columns. Endcapped columns show decreased retention for hydrogen bond acceptors, such as ionized bases, and increased retention for protonated bases.
The Trinity test was the first nuclear weapon explosion conducted as part of the US Manhattan Project. There were no warnings to residents about the fallout, nor information about shelters or possible evacuations. This was followed in 1946 by tests in the Marshall Islands (Operation Crossroads), as recounted by chemist Harold Carpenter Hodge (1904-1990), toxicologist for the Manhattan Project, in his lecture (1947) as president of the International Association for Dental Research. Hodge's reputation was severely damaged by historian Eileen Welsome's 1999 Pulitzer Prize-winning book The Plutonium Files - America's Secret Medical Experiments in the Cold War. She documents horrific human experiments in which the subjects (including Hodge) were unaware that they were being used as "guinea pigs" to test the safety limits of uranium and plutonium. The experiments on the unidentified subjects were continued by the United States Atomic Energy Commission (AEC) into the 1970s. The abuse of radiation continues to this day. During the Cold War, ethically reprehensible radiation experiments were conducted in the United States on untrained human subjects to determine the detailed effects of radiation on human health. Between 1945 and 1947, 18 people were injected with plutonium by Manhattan Project doctors. In Nashville, pregnant women were given radioactive mixtures. In Cincinnati, about 200 patients were irradiated over a 15-year period. In Chicago, 102 people received injections of strontium and caesium solutions.
== History == Although the applications of pharmacometabolomics to personalized medicine are largely only being realized now, the study of an individual's metabolism has been used to treat disease since the Middle Ages. Early physicians employed a primitive form of metabolomic analysis by smelling, tasting and looking at urine to diagnose disease. Obviously the measurement techniques needed to look at specific metabolites were unavailable at that time, but such technologies have evolved dramatically over the last decade to develop precise, high-throughput devices, as well as the accompanying data analysis software to analyze output. Currently, sample purification processes, such as liquid or gas chromatography, are coupled with either mass spectrometry (MS)-based or nuclear magnetic resonance (NMR)-based analytical methods to characterize the metabolite profiles of individual patients. Continually advancing informatics tools allow for the identification, quantification and classification of metabolites to determine which pathways may influence certain pharmaceutical interventions. One of the earliest studies discussing the principle and applications of pharmacometabolomics was conducted in an animal model to look at the metabolism of paracetamol and liver damage. NMR spectroscopy was used to analyze the urinary metabolic profiles of rats pre- and post-treatment with paracetamol. The analysis revealed a certain metabolic profile associated with increased liver damage following paracetamol treatment.
Russian and US diplomats said their diplomatic relations were worse than during the 1962 Cuban Missile Crisis. Kremlin spokesperson Dmitry Peskov told a reporter of a Russian state-run television network, "We are taking steady steps towards the Cold War ... All the attributes of the Cold War with the direct confrontation are returning." Polish retired general and defense analyst Stanisław Koziej wrote in 2024 that "A second cold war against the West is intensifying in Europe. Russia launched it by annexing Crimea in 2014 and following up with a full-scale armed invasion of Ukraine". He said that "this cold war is similar to the first one" but differs in that "it employs a bigger toolbox of activities that are often referred to as 'hybrid' or in the gray zone". Koziej highlighted recent Russian hybrid warfare operations against eastern NATO states, including sabotage, cyberattacks, airspace violations, espionage, weaponized migration, disinformation operations and nuclear blackmail. Sabine Siebold, Senior European Security correspondent for Reuters, also cited Russian hybrid warfare and NATO troop build-ups as evidence that there was a "new Cold War" between Russia and NATO. She added, "in some ways, it even feels hotter than the Cold War in the 80s. This time we have a war raging on European territory involving Russian forces and Western weapons and many arms control treaties that were in place in the 80s have collapsed in the meantime".
Calcium alginate is used in different types of medical products, including skin wound dressings, in the form of hydrogels, to promote healing, since alginate can increase the fluid uptake capacity of dressings, reducing the amount of times the dressing needs to be changed.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It mimics a natural hypothalamic signal that tells the pituitary to release growth hormone. The result is a rise in circulating growth hormone and, indirectly, in insulin-like growth factor 1. Over weeks of treatment this shift is associated with a selective decrease in fat stored inside the abdomen.